David C Hastings Entasis Therapeutics Holdings Inc. (ETTX) insider trading activity

ETTX Quotes by TradingView

David C Hastings is Director of Entasis Therapeutics Holdings Inc.. Currently has a direct ownership of 0 shares of ETTX, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2022, when has been sold 27,500 shares (Common Stock) at a price of $2.2 per share, resulting in proceeds of $60,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DAVID C HASTINGS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2022
SELL
Sale (or disposition) back to the issuer
$60,500 $2.2 p/Share
27,500 Reduced 100.0%
0 Common Stock
Jul 07 2022
SELL
Disposition due to a tender of shares in a change of control transaction
$48,400 $2.2 p/Share
22,000 Reduced 100.0%
0 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
27,500 Added 35.71%
49,500 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
-
22,000 Added 50.0%
22,000 Common Stock

Also insider at

ABUS
Arbutus Biopharma Corp Healthcare
Chief Financial Officer
SCYX
SCYNEXIS INC Healthcare
DCH

David C Hastings

Director
Waltham, MA

Track Institutional and Insider Activities on ETTX

Follow Entasis Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETTX shares.

Notify only if

Insider Trading

Get notified when an Entasis Therapeutics Holdings Inc. insider buys or sells ETTX shares.

Notify only if

News

Receive news related to Entasis Therapeutics Holdings Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETTX